September 30, 2025 · Form 4 insider transaction
Feeley Kevin sold 70 shares of GeneDx Holdings Corp. at $113.68 per share, a transaction worth $8.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.; Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 3,392 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 25,906 shares of Class A common stock, which RSUs and options vest according to their respective terms.